[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-338240-105":59,"doc-detail-338240-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","network-pharmacology-based-investigation-and-experimental-validation-of-the-mechanism-of-metformin-in-the-treatment-of-acute-myeloid-leukemia","Network pharmacology-based investigation and experimental validation of the mechanism of metformin in the treatment of acute myeloid leukemia","","Metformin is a widely used anti-diabetic drug with reported anti-cancer effects in multiple malignancies, including acute myeloid leukemia (AML). The precise mechanisms through which metformin impacts AML remain unclear. Using a combined network pharmacology and experimental validation workflow, the study identifies and analyzes metformin targets and AML-related genes, then builds a target–gene network via biomedical databases. Protein–protein interaction, gene ontology, and KEGG analyses indicate that metformin suppresses AML cell proliferation and triggers apoptosis via the AKT/HIF1A/PDK1 signaling pathway, informing clinical AML applications.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/network-pharmacology-based-investigation-and-experimental-validation-of-the-mechanism-of-metformin-in-the-treatment-of-acute-myeloid-leukemia/338240/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/network-pharmacology-based-investigation-and-experimental-validation-of-the-mechanism-of-metformin-in-the-treatment-of-acute-myeloid-leukemia/338240.png","ImageObject",300,407,{"name":92,"@type":93},"Riley","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-12","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",18,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"Why is the mechanism of metformin in acute myeloid leukemia still important to study?","Question",{"text":113,"@type":114},"Although metformin shows anti-cancer potential in AML, prior findings are inconsistent and the exact mechanism of action is not fully understood.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What research approach does the study use to investigate metformin’s AML targets?",{"text":118,"@type":114},"It applies network pharmacology together with experimental validation to identify potential metformin targets and AML-related genes, then constructs a target–gene network using biomedical databases.",{"name":120,"@type":111,"acceptedAnswer":121},"Which signaling pathway is reported to mediate metformin’s effects in AML?",{"text":122,"@type":114},"The results indicate apoptosis induction and proliferation inhibition through the AKT/HIF1A/PDK1 signaling pathway.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},338240,1790212760,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":41,"preview_page_count":19,"preview_urls":146},1374391975076,"https://ap-avatar.wpscdn.com/avatar/14000253ca4ec9f6853?x-image-process=image/resize,m_fixed,w_180,h_180&k=1783305029341752051","Liu et al. European Journal  \nEuropean Journal of Medical Research (2024) 29:475  \n[https://doi.org/10.1186/s40001-024-02022-z](https://doi.org/10.1186/s40001-024-02022-z of Medical Research)[ of Medical Research](https://doi.org/10.1186/s40001-024-02022-z of Medical Research)  \n RESEARCH Open Access  \nNetwork pharmacology-based investigation   and experimental validation of the mechanism of metformin in the treatment of acute myeloid leukemia  \nShaoyu Liu1,2, Mingming Xu1,2,3, Zhuofan Yang1,2,4, Yangzi Li1,2, Depei Wu1,2 and Xiaowen Tang1,2*  \nAbstract  \nMetformin, a widely used anti-diabetic agent, has shown significant anti-cancer properties as reported in in various cancers, including acute myeloid leukemia. However, the detailed mechanisms by which metformin influences acute myeloid leukemia remain unrevealed. Employing a synergistic approach of network pharmacology and experimental validation, this study systematically identifies and analyzes potential metformin targets and AML-related genes. These findings are then cross-referenced with biomedical databases to construct a target-gene network, providing insights into metformin’s pharmacodynamics in AML treatment. Protein–Protein Interaction (PPI), Gene Ontology (GO), and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses are utilized. Results show metformin’s effectiveness in inhibiting AML cell proliferation and inducing apoptosis through the AKT/HIF1A/PDK1 signaling pathway. This research provides insights into metformin’s clinical application in AML treatment.  \nKeywords Network pharmacology, Metformin, AML, Apoptosis, HIF1A  \nIntroduction  \nAcute myeloid leukemia (AML) is a highly heterogeneous hematologic malignancy, typically diagnosed in individuals aged between 60 and 70 years. It is characterized by a differentiation block in myeloid progenitor cells and uncontrolled proliferation of leukemia cells. The treatment response and overall prognosis of AML  \n*Correspondence: Xiaowen Tang [xwtang1020@163.com](xwtang1020@163.com)  \n1 National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China  \n2 Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China  \n3 Tianjin Medical University General Hospital, Tianjin, China  \n4 The 1st affiliated hospital,Jiangxi Medical College, Nanchang University, Nanchang, China  \nvary significantly, influenced by various patient- and tumor-specific factors, including age, performance status, and karyotype. The five-year survival rate for AML patients remains low, at approximately 21%[1, 2]. AML patients used to have limited treatment options, depending solely on cytarabine + anthracycline (7 + 3) intensive chemotherapy and hypomethylating agents [3]. Recent years have witnessed a therapeutic renaissance in AML treatment, spurred by an enhanced understanding of its genomic landscape. Novel therapies such as B-cell leukemia/lymphoma-2 inhibitors, FMS-like tyrosine kinase 3 (FLT3) inhibitors, and chimeric antigen receptor T-cell (CAR-T) therapy have entered clinical use [4, 5]. However, despite these advancements, AML relapse remains common after post-intensive chemotherapy and allogeneic stem cell transplantation (allo-HSCT). Consequently, identifying new therapeutic targets and  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in ","cbCaignALYvqFu14","https://ap.wps.com/l/cbCaignALYvqFu14","pdf",3807287,12,"English","# Abstract\n# Introduction\n## Background of AML and current therapies\n## Rationale for metformin in cancer and AML\n## Why network pharmacology and study approach","[{\"question\":\"Why is the mechanism of metformin in acute myeloid leukemia still important to study?\",\"answer\":\"Although metformin shows anti-cancer potential in AML, prior findings are inconsistent and the exact mechanism of action is not fully understood.\"},{\"question\":\"What research approach does the study use to investigate metformin’s AML targets?\",\"answer\":\"It applies network pharmacology together with experimental validation to identify potential metformin targets and AML-related genes, then constructs a target–gene network using biomedical databases.\"},{\"question\":\"Which signaling pathway is reported to mediate metformin’s effects in AML?\",\"answer\":\"The results indicate apoptosis induction and proliferation inhibition through the AKT/HIF1A/PDK1 signaling pathway.\"}]","Network pharmacology-based investigation and experimental validation of the mechanism of metformin in the treatment of acute myeloid leukemia | PDF",1790022690,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1b75d30f1aacd841eafcc5b7734dab2e.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0a2ed7d62f77c688b85ff4576036e540.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cfd38b51e42209eac2374978175b38ee.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/798625ac83e31099be363d67865aaf8f.webp",980,1301]